Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 2
2009 1
2011 2
2012 1
2014 2
2015 5
2016 3
2017 6
2018 3
2019 4
2020 6
2021 6
2022 5
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Testing strategies for the safety of nanoparticles used in medical applications.
Dusinska M, Dusinska M, Fjellsbø L, Magdolenova Z, Rinna A, Runden Pran E, Bartonova A, Heimstad E, Harju M, Tran L, Ross B, Juillerat L, Halamoda Kenzaui B, Marano F, Boland S, Guadaginini R, Saunders M, Cartwright L, Carreira S, Whelan M, Kelin Ch, Worth A, Palosaari T, Burello E, Housiadas C, Pilou M, Volkovova K, Tulinska J, Kazimirova A, Barancokova M, Sebekova K, Hurbankova M, Kovacikova Z, Knudsen L, Poulsen M, Mose T, Vilà M, Gombau L, Fernandez B, Castell J, Marcomini A, Pojana G, Bilanicova D, Vallotto D. Dusinska M, et al. Among authors: palosaari t. Nanomedicine (Lond). 2009 Aug;4(6):605-7. doi: 10.2217/nnm.09.47. Nanomedicine (Lond). 2009. PMID: 19663587 Free article. No abstract available.
Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST.
Dusinska M, Boland S, Saunders M, Juillerat-Jeanneret L, Tran L, Pojana G, Marcomini A, Volkovova K, Tulinska J, Knudsen LE, Gombau L, Whelan M, Collins AR, Marano F, Housiadas C, Bilanicova D, Halamoda Kenzaoui B, Correia Carreira S, Magdolenova Z, Fjellsbø LM, Huk A, Handy R, Walker L, Barancokova M, Bartonova A, Burello E, Castell J, Cowie H, Drlickova M, Guadagnini R, Harris G, Harju M, Heimstad ES, Hurbankova M, Kazimirova A, Kovacikova Z, Kuricova M, Liskova A, Milcamps A, Neubauerova E, Palosaari T, Papazafiri P, Pilou M, Poulsen MS, Ross B, Runden-Pran E, Sebekova K, Staruchova M, Vallotto D, Worth A. Dusinska M, et al. Among authors: palosaari t. Nanotoxicology. 2015 May;9 Suppl 1:118-32. doi: 10.3109/17435390.2014.991431. Nanotoxicology. 2015. PMID: 25923349 Review.
Cohort Profile: The Cardiovascular Research Data Catalogue.
Reinikainen J, Palosaari T, Canosa-Valls AJ, Schmidt CO, Wissa R, Chadalavada S, Codó L, Gelpí JL, Joseph B, van der Lugt A, Pacella E, Petersen SE, Pujadas ER, Szabo L, Zeller T, Niiranen T, Lekadir K, Kuulasmaa K. Reinikainen J, et al. Among authors: palosaari t. Int J Epidemiol. 2024 Feb 1;53(1):dyad175. doi: 10.1093/ije/dyad175. Int J Epidemiol. 2024. PMID: 38142238 No abstract available.
Extrapolating from acute to chronic toxicity in vitro.
Macko P, Palosaari T, Whelan M. Macko P, et al. Among authors: palosaari t. Toxicol In Vitro. 2021 Oct;76:105206. doi: 10.1016/j.tiv.2021.105206. Epub 2021 Jun 26. Toxicol In Vitro. 2021. PMID: 34186185 Free PMC article.
Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy Men and Women: The MORGAM Project.
Vishram-Nielsen JKK, Kristensen AMD, Pareek M, Laurent S, Nilsson PM, Linneberg A, Greve SV, Palmieri L, Giampaoli S, Donfrancesco C, Kee F, Mancia G, Cesana G, Veronesi G, Grassi G, Kuulasmaa K, Salomaa V, Palosaari T, Sans S, Ferrieres J, Dallongeville J, Söderberg S, Moitry M, Drygas W, Tamosiunas A, Peters A, Brenner H, Grimsgaard S, Savallampi M, Olsen MH. Vishram-Nielsen JKK, et al. Among authors: palosaari t. Hypertension. 2021 Apr;77(4):1076-1085. doi: 10.1161/HYPERTENSIONAHA.120.16354. Epub 2021 Mar 1. Hypertension. 2021. PMID: 33641358
Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE project.
Rehm M, Rothenbacher D, Iacoviello L, Costanzo S, Tunstall-Pedoe H, Fitton CA, Söderberg S, Hultdin J, Salomaa V, Jousilahti P, Palosaari T, Kuulasmaa K, Waldeyer C, Schnabel RB, Zeller T, Blankenberg S, Koenig W; BiomarCaRE Consortium. Rehm M, et al. Among authors: palosaari t. ESC Heart Fail. 2022 Feb;9(1):57-65. doi: 10.1002/ehf2.13699. Epub 2021 Nov 26. ESC Heart Fail. 2022. PMID: 34825788 Free PMC article.
Risk prediction of atrial fibrillation in the community combining biomarkers and genetics.
Börschel CS, Ohlrogge AH, Geelhoed B, Niiranen T, Havulinna AS, Palosaari T, Jousilahti P, Rienstra M, van der Harst P, Blankenberg S, Zeller T, Salomaa V, Schnabel RB. Börschel CS, et al. Among authors: palosaari t. Europace. 2021 May 21;23(5):674-681. doi: 10.1093/europace/euaa334. Europace. 2021. PMID: 33458771 Free PMC article.
49 results